The application is now open for the 2021 Flinn Foundation Bioscience Entrepreneurship Program, which offers funding, professional support, and networking opportunities to Arizona early-stage bioscience firms.
The program provides $30,000 in non-dilutive funding support for up to six firms each year, administered through a nonprofit partner, and a professionally developed, yearlong plan specific to the needs of the individual firms.
Opportunities are extended to the competitively selected firms to engage with the state’s bioscience, academic, and policy leaders, including membership for one year on Arizona’s Bioscience Roadmap Steering Committee.
The application is now open. The deadline to apply is Nov. 2.
The Flinn Foundation created the program to foster entrepreneurship and help early-stage bioscience firms develop into successful and sustainable businesses—a goal of Arizona’s Bioscience Roadmap, the long-term strategic plan to advance Arizona’s bioscience sector. Since 2014, nearly $1.2 million in funding support has been provided to 40 Arizona bioscience firms.
To be eligible for the program, an entity must be a bioscience firm engaged in the commercialization of bioscience research and biotechnology and/or the sale of products in the areas of:
- Medical devices and equipment;
- Drugs, pharmaceuticals and diagnostics;
- Agricultural feedstock and chemicals;
- Research, testing and medical labs; or
- Bioscience-related distribution.
Additional information about the program and application process can be found in the 2021 Bioscience Entrepreneurship Program Brochure and at flinn.org/entrepreneur.
Any questions about the program or application process should be directed to Flinn Foundation Program Manager Juliet Gomez.